SKELAXIN
What it isCentral muscle relaxant of uncertain mechanism; acute musculoskeletal spasm.
Why this oneIt impairs alertness less than many skeletal muscle relaxants, but direct evidence of benefit is unusually thin.
What limits itFood raises exposure, and alcohol or opioids amplify sedation; rare hemolytic anemia and hepatotoxicity occur.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Acute painful musculoskeletal conditions (adjunct) | Adults & children >12 yr | 800 mg TID–QID | 800 mg TID–QID | 3200 mg/day |
Renal Contraindicated in significantly impaired renal function
Hepatic Contraindicated in significantly impaired hepatic function
Pregnancy Safe use not established; should not be used in women who are or may become pregnant, particularly in early pregnancy, unless benefit outweighs hazard
Lactation Undefined
NO BOXED WARNINGS
Principal riskWeak efficacy evidence; take with food
Cost, est. cash$10–$300/month
Generic entry2010
Legacy pregnancy categoryUnknown / historical label unavailable
Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.

Open Metaxalone in the interactive console ↗

